LEONARD P. STARK, District Judge.
WHEREAS, Magistrate Judge Burke issued a 27-page Report and Recommendation ("Report") (D.I. 704), dated April 20, 2018, recommending that the Court: (1) grant in part and deny in part Plaintiffs Integra LifeSciences Corp., Integra LifeSciences Sales LLC, Confluent Surgical, Inc., and Incept LLC's (collectively, "Plaintiffs" or "Integra") motion for summary judgment of infringement of claim 10 of the '034 patent (D.I. 399); (2) deny Defendant HyperBranch Medical Technology, Inc.'s ("Defendant" or "HyperBranch") motion for summary judgment of invalidity of claim 10 of the '034 patent for obviousness (D.I. 393); and (3) deny as moot Defendant's motion for summary judgment of non-infringement of the "mixing" limitation of certain claims of the '5705 patent (id.);
WHEREAS, on April 30, 2018, HyperBranch objected to the Report (D.I. 709) ("Objections" or "Objs."), asserting it incorrectly construed the term "the hydrogel forms within 5 seconds" and incorrectly recommended summary judgment of indirect infringement;
WHEREAS, on May 10, 2018, Plaintiffs responded to HyperBranch's Objections (D.I. 717) ("Response" or "Resp.");
WHEREAS, on May 15, 2018, during the pretrial conference in this matter, the Court heard extensive argument from the parties relating to the Objections (see Tr. at 115-30);
WHEREAS, the Court has considered the parties' objections and responses de nova, see St. Clair Intellectual Prop. Consultants, Inc. v. Matsushita Elec. Indus. Co., Ltd., 691 F.Supp.2d 538, 541-42 (D. Del. 2010); 28 U.S.C. § 636(b)(1); Fed. R. Civ. P. 72(b);
NOW THEREFORE, IT IS HEREBY ORDERED that:
1. HyperBranch's Objections (D.I. 709) are SUSTAINED, Judge Burke's Report (D.I. 704) is REJECTED to the extent described herein, and Plaintiffs' motion (D.I. 399) is DENIED.
2. HyperBranch contends the Report is "flawed in two key respects:" (1) its construction of the term "the hydro gel forms within 5 seconds" and (2) its reliance on evidence that is not dispositive of infringement when that claim term is properly construed. (Objs. at 4-5)
3. The parties are unable even to agree on how the Report construed the term "the hydrogel forms within 5 seconds." In Defendant's view, "the Report purports to construe `the hydrogel forms within 5 seconds' as a `fully cured' hydrogel forms in 5 seconds — not initial gel formation occurs in 5 seconds." (Id. at 4) Plaintiffs, however, read the Report as "properly conclud[ing] that the claim limitation `the hydrogel forms `is `met at the point when the material has cured and "a visible solid aggregate has been formed'" and this point can be determined `by way of a visual inspection.'" (Resp. at 1) In the Court's understanding, the Report found that the "forms within 5 seconds" limitation is met "at the point when the material has cured and a `visible solid aggregate has been formed,'" and that this point can be determined "by way of a visual inspection." (Report at 10)
4. Considering this claim construction dispute de novo, the Court concludes that "the hydrogel forms within 5 seconds" is properly construed as "a visual solid aggregate forms within 5 seconds."
5. To the extent Defendant suggests the term must be construed such that it is only satisfied if the hydrogel is fully formed (or fully cured) within 5 seconds, so that no additional crosslinking may occur after the point at which "the hydrogel forms," the Court is not persuaded. (See Objs. at 2 ("Either `the hydrogel forms' is related to gel formation at the `gel time' and the claim is indefinite, or the claim requires a `fully cured' hydrogel and Plaintiffs[] have
6. The evidence on which the Report relied in recommending that summary judgment of infringement be granted may relate to gel formation, and not to a hydro gel being fully cured. Reviewing the record de novo, the Court determines that genuine disputes of material fact exist regarding whether the "hydrogel forms within 5 seconds" in the accused products. Therefore, summary judgment of infringement is not warranted.